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Abstract: This study was designed to determine antiproliferative properties of curcusone B from the
stem bark of Jatropha curcas on cell lines K562 (chronic myelogeneous leukemia), and H1299
(human non-small cell lung carcinoma). Cells were cultured in the presence of curcusone B at various
concentrations and the percentage of cell viability was evaluated by trypan blue exclusion method and
MTT assay. Curcusone B showed significant dose-dependent inhibition of cell proliferation of K562
and H1299 cell lines with an IC50 of 6 µg/mL and 15.0 µg/mL, respectively. The findings suggested
that the curcusone B had strong antiproliferation which was dose dependent and may have potential
as an anticancer agent.
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INTRODUCTION
Cancer is a leading cause of death worldwide with increasing morbidity and mortality. It can affect any
part of the body (Katzung, 2007). Cytotoxic chemotherapy has been one of the mainstays of cancer treatment
for many years and is also said to be the most rapidly developing field of cancer treatment, with new drugs
which include plant metabolites being constantly screened and tested (Kintzios and Barberaki, 2003). J. curcas
(family Euphorbiaceae), also known as physic nut, purging nut or pig nut, is a multipurpose bush/small tree
popular for both economic (Akbar  et al., 2009a) and medicinal uses (Akbar et al., 2009b). It is originally from
tropical America, but also distribute in many parts of the tropics and sub-tropics in Africa-Asia. As with many
Jatropha species, J. curcas is used in the traditional folklore medicine to cure various ailments in Africa, Asia,
and Latin America (Burkill, 1994). Leaves and roots are used as a remedy for cancer, as an abortifacient,
antiseptic, diuretic, purgative, external application for the treatment of skin diseases, sores, rheumatism, piles
and as an antidote for snake-bites. The nut of the plant has also been used for the treatment of burns,
convulsions, fever and inflammation. Other uses from its oil include soap making, illumination, cosmetics,
organic manure and most recently as a potential alternative to diesel (Akbar et al., 2009a; Kumar  and Sharma,
2005; Osoniyi and Onajobi, 2003). Studies have revealed that the plant contains phytochemicals such as
saponins, steroids, tannins, glycosides, alkaloids and flavonoids, and some of them exhibit significant biological
activity (Akbar et al., 2009a; Akbar et al., 2009b).  Curcusone B is one of the four curcusones isolated from
the roots of Jatropha curcas and belongs to the crotophorbolane class of compounds (Naengchomnong et al.,
1986). Curcusone B isolated from the stem barks of J. curcas (Ardiansyah et al., 2009) was reported to possess
potential antimicrobial and anticancer activity. From the above traditional uses and later scientific findings
suggested that J. curcas is a potential candidate as an antimicrobial and anticancer agent. To the best of our
knowledge, there is no publication available on the possible antiproliferative activity of curcusones from J.
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curcas on human cancer cells. Therefore, the possibility to obtain such findings is high and may provide
interesting information on the plant’s activity as an anticancer.
Experimental:
Reagents: 
RPMI 1640 medium, Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum (FBS) and
Penicillin-Streptomycin were obtained from GIBCO/Invitrogen (Auckland, NZ);  Thiazolyl Blue Tetrazolium
Bromide (MTT) from Sigma-Aldrich (USA) and dimethyl sulphoxide (DMSO) from Merck (Germany).
Plant Material: 
The stem bark of J. curcas was obtained from Collection and Development Centre for Traditional
Medicine of South East Celebes Community, Arboretum Prof. Mahmud Hamundu, Haluoleo University. This
plant had been identified by staff of Herbarium Bogoriense, Bogor. Ground-powder of J. curcas stembark (1.0
kg) was macerated with methanol (3 x 3L) for 3 days. Methanol extract was concentrated at low pressure and
dark brown gum was obtained (100 g) as previously described (Ardiasyah et al., 2009). Using vacuum column
chromatography, the extract was subsequently rechromatographed until 0.3 g of pure compound was yielded
eventually. The compound was kept at 4 °C and dissolved in dimethyl sulphoxide DMSO to make a
concentration of 10 mg/ml.
Cell culture: 
K-562 cell line was obtained from the American Type Culture Collection (Rockville, MD) and was
cultured in RPMI 1640.  H1299 cell lines were a courtesy of Prof. Masa-Aki Ikeda of Tokyo Medical and
Dental University and were cultured in DMEM medium. All media were supplemented with 10% (v/v) FBS,
100 mg/L of streptomycin and 100,000 U/L of penicillin.
Cell Proliferation Assay:
K-562 cell line. Columns of a 48-well microplate were seeded with 250 µl of cell suspension per well and
serial dilutions of curcusone B were immediately added. Solvent controls were treated with 0.1% DMSO. Cells
were then incubated for 48 h. A hemacytometer count for both control and treatment groups was done with
trypan blue under light microscope. The antiproliferative rate for each concentration was determined according
to the following equation.  
H1299 Cell Lines: 
Columns of 96-well microplates were seeded with 100 µl of cell suspension per well and incubated for
72 h in a CO2 incubator at 37 °C in humidified 5% CO2 atmosphere. Serial dilutions of curcusone B (50 µl)
were then added into each of 96-well plates. The cells were then incubated for another 48 hrs. After
incubation, the medium was removed and cells in each well were incubated with PBS contained 1 mg/mL
MTT for 24 h at 37 in 5% CO2 incubator. After this 100 µl of DMSO was added into each well to dissolve
the insoluble formazan crystal. Plates were then incubated for 4 h at 37°C for complete solubilization. The
level of colored formazan derivative was analysed on a microplate reader (Tecan) at a wavelength of 570 nm
(Abe and Matsuki, 2000). The percentage viability of the cells was calculated using the following equation.
Where; Abs. = Absorbance
Statistical Analysis: 
The experiments were done in triplicates to generate statistically relevant data and the results were
expressed as mean ± SD using the SPSS 15.0 software program, statistical analysis was done with Two Way
Anova. p<0.05 was considered statistically significant.
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RESULTS AND DISCUSSION
Effect of Curcusone B on the Proliferation of K-562 Human Leukemia Cell Line:
The relationship between the concentration of curcusone B and its cytotoxic effect on proliferation of K562
chronic leukemia cell line was investigated by trypan blue exclusion assay. Cells were treated with curcusone
B at concentrations ranging from 3.13 to 100 ug/mL for 48 h and then the percentage of cell viability was
analysed as described above. The mean % viability obtained at different compound concentrations is shown
in Table 1. Values have been expressed as mean ± SD (n=3). 
Table 1: % Viability of K562 cell line after treatment with different concentrations of  Curcusone B.
Sample % Viability at different concentrations
----------------------------------------------------------------------------------------------------------------------------------------------------
100 µg/mL 50 µg/mL 25 µg/mL 12.5 µg/mL 6.25ug/mL 3.13 µg/mL
Curcusone B 1.30±1.84 3.35±1.48 13.95±1.06 30.63±0.88 49.90±2.26 65.20±0.42
DMSO 92.35±7.99 88.35±4.73 95.10±0.57 91.90±9.05 96.60±1.83 99.30±0.99
Curcusone B from the stem bark of J.curcas significantly inhibited the proliferation of K562cells
(P<0.001), in a dose-dependent manner (Figure 1). The IC50 was observed at 6 µg/mL by graphical
interpolation.
Fig. 1: Effect of curcusone B on the proliferation of K562 cell line. The percentage viability was determined
with trypan blue exclusion assay. Data represents the means ± SD (n=3). IC50 was estimated at 6
µg/ml. 
Effect of Curcusone B on the Proliferation of H1299 Human Non-small Cell Lung Cell Line:
The relationship between the concentration of curcusone B and its cytotoxic effect on proliferation of
H1299 cell lines was investigated by MTT assay. Cells were treated with curcusone B at concentrations
ranging from 3.13 to 100 µg/mL for 48 h and then the percentage of cell viability was analyzed as described
before. The mean absorbance obtained after treatment of H1299 cell line with different compound
concentrations is shown in Table 2. Values have been expressed as mean ± SD (n=3). 
Table 2: Mean absorbance obtained after treatment of H1299 cell line with different concentrations of Curcusone B 
Sample Mean absorbance at different concentrations
----------------------------------------------------------------------------------------------------------------------------------------------------
100 µg/mL 50 µg/mL 25 µg/mL 12.5 µg/mL 6.25 µg/mL 3.13 µg/mL
Curcusone B 0.187±0.006 0.439±0.034 0.514±0.013 0.842±0.038 0.971±0.013 1.232±0.175
DMSO 0.507±0.031 1.211±0.041 1.308±0.074 1.563±0.033 1.501±0.060 1.899±0.153
Curcusone B showed significant inhibition (p= 0.018) of the proliferation of H1299 cells in a dose-
dependent manner (Figure 2). The IC50 was observed at 15µg/ml by graphical interpolation. 
Although J. curcas has long been used as traditional medicine, few scientific studies in the field of cancer
therapy are available. Recent in vitro studies have shown that many constituents from J. curcas have a wide
range of biological actions including antibacterial, antifungal, antiparasitic, haemostatic and strong anti HIV-
induced cytopathic effects with low cytotoxicity (Akbar et al., 2009a;  Osoniyi and Onajobi, 2003). Studies
have revealed that J. curcas is a source of saponins, steroids, tannins, glycosides, alkaloids, and flavonoids
(Akbar et al., 2009b) and some of them have relevant biological activities. 
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Fig. 2: Effect of curcusone B on the proliferation of H1299 cell line. The percentage viability was determined
with MTT assay. Data represent  the means ± S.D. (n =3).  IC50 was estimated at 15 µg/ml.
In this study, the antiproliferative activity by curcusone B from the stem bark of  J. curcas on human
cancer cell lines was investigated. It was found that curcusone B significantly inhibited the proliferation of K-
562 and H1299 cells after an incubation period of 48h. The antiproliferative effect was evaluated by trypan
blue exclusion and MTT assays respectively.
The results presented have shown a concentration dependant decrease in the percentage of cell viability
and, at a concentration of 3.13-100 µg/ml, curcusone B was sufficient to inhibit the cell proliferation of K562
and H1299. Thus curcusone B displayed strong antiproliferative activity on both human chronic myelogenous
leukemia and non-small cell lung carcinoma cells with an IC50 of 6.1µg/mL and 15µg/mL, respectively.
In conclusion, the results demonstrated that curcusone B from the stem bark of J. curcas has a significant
antiproliferative effect. This is in line with findings from previous studies that have revealed the potential of
J. curcas in possessing relevant antimicrobial and anticancer effects.  One study (Zeng et al, 2004) determined
the in vitro antibiotic effect of an alcohol extract from jatropha leaf on Escherichia coli and Staphylococcus
aureus. The extract inhibited E. coli and S. aureus, and the activity against E. coli was better than that against
S. aureus. Curcin, from seeds of J. curcas, was found to be a ribosome inactivating protein (RIP) in a study
which revealed the functional mechanism of curcin at molecular level for the first time. It was discovered that
curcin had an antitumor effect with mechanisms of action related to N-glycosidase activity (Lin et al., 2002;
Lin and Chen, 2003; Lin et al., 2003). The present study reveals for the first time that curcusone B from the
stem bark of J. curcas exhibited a significant antiproliferative effect on K562 and H1299 cell lines.
These probable properties of J. curcas provide scope of further detailed investigation of purified
compounds from this plant because of their potential as antineoplastic agents.  Moreover, other biological
activities on different cell lines and microbial organisms which may be correlated to traditional treatments of
J. curcas should be invetigated as well as hematological disorders and chronic infetcions.
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